Philip Bonomi to Adenocarcinoma, Bronchiolo-Alveolar
This is a "connection" page, showing publications Philip Bonomi has written about Adenocarcinoma, Bronchiolo-Alveolar.
Connection Strength
0.020
-
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer. J Clin Oncol. 2007 Oct 20; 25(30):4743-50.
Score: 0.020